Global Distribution of Human Protoparvoviruses

dc.contributor.authorElina Väisänen
dc.contributor.authorUshanandini Mohanraj
dc.contributor.authorPaula M. Kinnunen1
dc.contributor.authorPikka Jokelainen
dc.contributor.authorHaider Al-Hello
dc.contributor.authorAli M. Barakat
dc.contributor.authorMohammadreza Sadeghi
dc.contributor.authorFarid A. Jalilian
dc.contributor.authorAmir Majlesi
dc.contributor.authorMoses Masika
dc.contributor.authorDufton Mwaengo
dc.contributor.authorOmu Anzala
dc.contributor.authorEric Delwart
dc.contributor.authorOlli Vapalahti
dc.contributor.authorKlaus Hedman
dc.contributor.authorMaria Söderlund-Venermo
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organization-code2607100
dc.converis.publication-id32503927
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/32503927
dc.date.accessioned2022-10-28T14:31:13Z
dc.date.available2022-10-28T14:31:13Z
dc.description.abstractDevelopment of next-generation sequencing and metagenomics has revolutionized detection of novel viruses. Among these viruses are 3 human protoparvoviruses: bufavirus, tusavirus, and cutavirus. These viruses have been detected in feces of children with diarrhea. In addition, cutavirus has been detected in skin biopsy specimens of cutaneous T-cell lymphoma patients in France and in 1 melanoma patient in Denmark. We studied seroprevalences of IgG against bufavirus, tusavirus, and cutavirus in various populations (n = 840), and found a striking geographic difference in prevalence of bufavirus IgG. Although prevalence was low in adult populations in Finland (1.9%) and the United States (3.6%), bufavirus IgG was highly prevalent in populations in Iraq (84.8%), Iran (56.1%), and Kenya (72.3%). Conversely, cutavirus IgG showed evenly low prevalences (0%-5.6%) in all cohorts, and tusavirus IgG was not detected. These results provide new insights on the global distribution and endemic areas of protoparvoviruses.
dc.format.pagerange1299
dc.identifier.jour-issn1080-6040
dc.identifier.olddbid188747
dc.identifier.oldhandle10024/171841
dc.identifier.urihttps://www.utupub.fi/handle/11111/55602
dc.identifier.urlhttps://wwwnc.cdc.gov/eid/article/24/7/17-2128_article
dc.identifier.urnURN:NBN:fi-fe2021042719451
dc.language.isoen
dc.okm.affiliatedauthorSadeghi, Mohammadreza
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherCENTERS DISEASE CONTROL
dc.relation.doi10.3201/eid2407.172128
dc.relation.ispartofjournalEmerging Infectious Diseases
dc.relation.issue7
dc.relation.volume24
dc.source.identifierhttps://www.utupub.fi/handle/10024/171841
dc.titleGlobal Distribution of Human Protoparvoviruses
dc.year.issued2018

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
25dde4d081f3dd141ee2c93ce43644804e23.pdf
Size:
1.1 MB
Format:
Adobe Portable Document Format